- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/86 - Hydrolases (3.) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase
Patent holdings for IPC class C12N 9/86
Total number of patents in this class: 163
10-year publication summary
24
|
18
|
13
|
13
|
9
|
10
|
11
|
16
|
6
|
6
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Theriva Biologics, Inc. | 83 |
36 |
Board of Regents, The University of Texas System | 5738 |
6 |
Synthetic Biologics, Inc. | 31 |
6 |
Bioaster | 51 |
6 |
da Volterra | 36 |
5 |
BASF SE | 20728 |
4 |
The Regents of the University of California | 19784 |
4 |
Danisco US Inc. | 1094 |
3 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3358 |
3 |
Memorial Sloan-Kettering Cancer Center | 1901 |
3 |
Queensland University of Technology | 117 |
3 |
Tianjin University | 783 |
3 |
Evonik Operations GmbH | 4032 |
3 |
Evonik Degussa GmbH | 1544 |
2 |
California Institute of Technology | 3958 |
2 |
The Board of Trustees of the Leland Stanford Junior University | 6329 |
2 |
Kaneka Corporation | 4488 |
2 |
Academia Sinica | 933 |
2 |
Enzymaster (Ningbo) Bio-Engineering Co., Ltd. | 45 |
2 |
Ipsat Therapies Oy | 2 |
2 |
Other owners | 64 |